Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

AquaVita NextGen vs Willow

AquaVita NextGen
Graded #415

Lower grade

vs+1.9000000000000057
Willow
Graded #377

Higher grade

The verdict

Willow takes it — 58.2/100 to 56.3/100, but only just.

Willow grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth provider offering compounded GLP-1 medications in both tablet and injectable formats. AquaVita NextGen is close behind and may still be the better fit — see the factor split below.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueWillow +13
23
36
Dose & formulationEven
75
75
Clinical oversightAquaVita NextGen +11
82
71
Labs & monitoringAquaVita NextGen +1
53
52
FulfillmentWillow +3
62
65
Contract termsWillow +8
47
55
AquaVita NextGen · left barWillow · right bar

The numbers

MetricAquaVita NextGenWillow
WeighScore56.3/10058.2/100
GradeCC
Scorecard rank#415#377
Semaglutide$375/mo (first-month rate, compounded)$299/mo (starting dose, compounded)
Tirzepatide$320/mo (starting dose, 3-month plan, compounded)$399/mo (starting dose, compounded)
Coverage5 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
AquaVita NextGen

Graded #415 · C

Strengths

  • Physical address in Lake Forest CA
  • Named medical director (Dr. Steve Groke)
  • Both semaglutide and tirzepatide including ODT tablets
  • Compounding disclaimer present on site

Where it loses points

  • Only 5 states (AZ, CA, FL, TX, NV)
  • No LegitScript or PCAB accreditation
  • Primarily a local medspa expanding into telehealth
  • Only a first-month semaglutide price ($375, originally $499) is published; ongoing monthly price and all tirzepatide pricing remain unpublished
Willow

Graded #377 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard